Professor Khaled Musallam, a notable UAE-based researcher, has been recognised with the EHA Clinical Excellence Award, making him the first Arab to receive this important international accolade.
The prise, given by the European Haematology Association (EHA), recognises Prof. Musallam’s pioneering contributions to thalassemia research and patient care, which have greatly expanded the study and treatment of the genetic blood illness in the region and beyond.
A Pioneer in Thalassemia Care
Professor Musallam’s clinical work has played an important influence in:
improving early diagnostic and care techniques for thalassemia
Developing international treatment guidelines.
Leading multi-center clinical studies that have transformed therapy techniques.
His dedication has not only enhanced the quality of life for innumerable patients, but has also established the UAE as a global leader in haematology research.
Honouring Regional Excellence
“This award is a recognition of years of collaboration, innovation, and an unwavering commitment to patient care,” Prof. Musallam stated during his acceptance speech.
A proud moment for the UAE
The award recognises the UAE’s expanding leadership in medical research and demonstrates the country’s dedication to addressing complex health concerns via scientific brilliance and innovation.
Prof. Musallam’s accomplishments serve as an inspiration to future generations of Arab researchers in the worldwide medical community.
